Trial | NCT00023166  Report issue

Title

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Terminated

  • Intervention/Treatment

    paclitaxel ...

  • Study Participants

    None
Studies of PEG-paclitaxel have been terminated
Study Started
May 31
2001
Study Completion
May 31
2002
Last Update
Jun 24
2005
Estimate

Drug PEG-paclitaxel

Criteria 

None - Study has been terminated.
No Results Posted